Haematologic Technologies

We provide holistic solutions for plasma-based protein therapies, monoclonal (mAbs) and polyclonal antibodies (pAbs), cell and gene therapies (CGTs), recombinant proteins, and vaccines and viral vectors. Our mission is to provide the highest quality services and products for the development of novel biotherapeutics and bring to life the therapeutics of tomorrow. We are passionate and driven to enable our clients’ success through superior science, partnership, and innovation. With over 30 years of experience, our staff has the expertise needed to identify and solve your most complex large molecule drug development challenges. Our dual focus on partnership and project management excellence means you have direct access to our scientific team throughout the course of your project, ensuring you receive accurate results faster. Prolytix is the sought-after partner in the local and scientific communities, supporting the area through community outreach, scientific engagement, and solving the biopharma industry’s most difficult challenges to bring life-changing therapies to the world. A protein chemistry authority since 1987, Prolytix has become a reliable partner for complex bioanalytical method development and validation. With expertise in host cell protein analysis, coagulation, and large molecule bioanalysis, you’ll find the capabilities you need at Prolytix.